NCT06446505 Evaluation of a Decision Aid for Deep Brain Stimulation Surgery for Parkinson's Disease
| NCT ID | NCT06446505 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Colorado, Denver |
| Condition | Parkinson Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 42 participants |
| Start Date | 2024-06 |
| Primary Completion | 2026-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 42 participants in total. It began in 2024-06 with a primary completion date of 2026-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn if a Decision Aid can help patients with Parkinson's disease make a decision about undergoing Deep Brain Stimulation surgery. The main questions it aims to answer are: * Is the Decision Aid acceptable to patients with Parkinson's disease considering Deep Brain Stimulation surgery? * Does the decision aid improve decision quality (informed, value-based decision) and uncertainty about the decision? Researchers will compare immediate use of the decision aid during the evaluation process for deep brain stimulation surgery to delayed introduction of the decision aid. Participants will: * Receive the decision aid at the beginning of the evaluation process or towards the end * Complete surveys at 5 visits (remote or in-person) over approximately 6 months
Eligibility Criteria
Inclusion Criteria: * Adults with a diagnosis of Parkinson's disease referred for deep brain stimulation surgery evaluation at the University of Colorado Exclusion Criteria: * Atypical Parkinsonism * Diagnosis of Dementia
Contact & Investigator
Michelle E Fullard, MD
PRINCIPAL INVESTIGATOR
University of Colorado, Denver
Frequently Asked Questions
Who can join the NCT06446505 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Parkinson Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06446505 currently recruiting?
Yes, NCT06446505 is actively recruiting participants. Contact the research team at michelle.fullard@cuanschutz.edu for enrollment information.
Where is the NCT06446505 trial being conducted?
This trial is being conducted at Aurora, United States.
Who is sponsoring the NCT06446505 clinical trial?
NCT06446505 is sponsored by University of Colorado, Denver. The principal investigator is Michelle E Fullard, MD at University of Colorado, Denver. The trial plans to enroll 42 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.